The research aims to determine if specific liver biopsy features can differentiate drug-induced autoimmune-like hepatitis from idiopathic autoimmune hepatitis.
Developed a scoring algorithm incorporating liver biopsy findings.
Evaluated histological activity index and liver biochemistry profiles.
Compared features between drug-induced and idiopathic autoimmune hepatitis.
The scoring algorithm effectively distinguishes between the two conditions.
Specific liver biopsy features correlate with diagnostic accuracy.
Incorporating HAI and liver biochemistry improves differentiation.
Abstract
A scoring algorithm that incorporates specific liver biopsy findings, HAI, and liver biochemistry profiles effectively distinguishes DI-ALH from iAIH.